DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Parker WT, Lawrence RM, Ho M. , et al.
Sensitive detection of BCR-ABL1 mutations in patients with chronic myeloid leukemia after imatinib resistance is predictive of outcome during subsequent therapy.
J Clin Oncol 2011;
29 (32) 4250-4259
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.